Systemic generalised lymphangiomatosis: Unknown aetiology and a challenge to treat

4Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

We describe a case of a woman diagnosed at the age of 35 years with a generalised mediastinal and abdominal lymphangiomatosis associated with a protein losing enteropathy, who successfully improved when treatment with sirolimus was initiated.

Author supplied keywords

References Powered by Scopus

Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies

646Citations
N/AReaders
Get full text

Targeted therapy in patients with PIK3CA-related overgrowth syndrome

402Citations
N/AReaders
Get full text

Sirolimus in the Treatment of Vascular Anomalies

189Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Genetic and Molecular Determinants of Lymphatic Malformations: Potential Targets for Therapy

12Citations
N/AReaders
Get full text

Laparoscopy for evaluating mesenteric lymphangiomatosis: A case report

3Citations
N/AReaders
Get full text

Diffuse abdominal lymphangiomatosis without tumoral masses: a case report

1Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Van Meerhaeghe, T., Vandenbroucke, F., & Velkeniers, B. (2021). Systemic generalised lymphangiomatosis: Unknown aetiology and a challenge to treat. BMJ Case Reports, 14(1). https://doi.org/10.1136/bcr-2020-237331

Readers' Discipline

Tooltip

Medicine and Dentistry 4

100%

Save time finding and organizing research with Mendeley

Sign up for free